ZENTALIS PHARMACEUTICALS INC's ticker is ZNTL and the CUSIP is 98943L107. A total of 107 filers reported holding ZENTALIS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,208,647 | -26.4% | 110,102 | +3.6% | 0.00% | -25.0% |
| Q2 2023 | $2,999,344 | +881.7% | 106,322 | +498.5% | 0.00% | – |
| Q1 2023 | $305,541 | -14.6% | 17,764 | 0.0% | 0.00% | -100.0% |
| Q4 2022 | $357,767 | -7.0% | 17,764 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $384,768 | -4.3% | 17,764 | +24.1% | 0.00% | 0.0% |
| Q2 2022 | $402,000 | -39.1% | 14,312 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $660,000 | -44.0% | 14,312 | +2.1% | 0.00% | -50.0% |
| Q4 2021 | $1,179,000 | +28.3% | 14,020 | +1.6% | 0.00% | 0.0% |
| Q3 2021 | $919,000 | +32.2% | 13,794 | +5.6% | 0.00% | +100.0% |
| Q2 2021 | $695,000 | +27.8% | 13,061 | +4.1% | 0.00% | 0.0% |
| Q1 2021 | $544,000 | -12.4% | 12,548 | +5.0% | 0.00% | 0.0% |
| Q4 2020 | $621,000 | – | 11,949 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 2,426,095 | $111,940,000 | 6.63% |
| Paradigm Biocapital Advisors LP | 287,577 | $13,269,000 | 3.51% |
| Avidity Partners Management LP | 3,176,999 | $146,587,000 | 3.05% |
| Integral Health Asset Management, LLC | 215,000 | $9,920,000 | 2.58% |
| Matrix Capital Management Company, LP | 4,349,279 | $200,676,000 | 2.41% |
| Affinity Asset Advisors, LLC | 207,500 | $9,574,000 | 1.53% |
| Ikarian Capital, LLC | 202,203 | $9,329,000 | 1.23% |
| Ghost Tree Capital, LLC | 80,000 | $3,691,000 | 0.80% |
| Eventide Asset Management | 761,000 | $35,113,000 | 0.55% |
| Perceptive Advisors | 501,509 | $23,140,000 | 0.46% |